- recruitingNA
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
This study looks at a new treatment called Apreo BREATHE for people with severe emphysema, a type of COPD. It tests if inserting small devices into airways can help release trapped air and improve breathing, alongside usual care.
United States · Austria · Netherlands - authorisedTherapeutic use (Phase IV)
A Phase 4, Multicenter, Double-blind, Study to Investigate the Efficacy, Safety, and Tolerability of 3 Active Doses of Respreeza® / Zemaira® Weekly Intravenous Infusions Administered over 3 Years as Longterm Maintenance Therapy in Adult Subjects with Emphysema Related to Alpha1 Antitrypsin Deficiency
This study looks at a medicine called Respreeza to see how well it helps adults with a lung condition called emphysema caused by Alpha-1 Antitrypsin Deficiency. It checks if the medicine improves breathing and is safe when given weekly for three years.
Denmark - active not recruitingPHASE2
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
This study looks at a new long-term treatment called SAR447537 for adults with lung damage (emphysema) caused by a condition called Alpha-1 Antitrypsin Deficiency (AATD). It will check how safe and effective this treatment is over time.
United States · Australia · Denmark